Atique U Ahmed Selected Research

GD3 ganglioside (GD(3))

12/2014

Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atique U Ahmed Research Topics

Disease

36	Neoplasms (Cancer) 12/2023 - 12/2007
27	Glioma (Gliomas) 01/2022 - 01/2013
18	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 01/2013
16	Brain Neoplasms (Brain Tumor) 10/2023 - 01/2012
8	Breast Neoplasms (Breast Cancer) 10/2023 - 05/2015
5	Hypoxia (Hypoxemia) 12/2023 - 01/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2007
2	Infections 09/2011 - 03/2011
2	Carcinogenesis 11/2008 - 12/2007
1	Circulating Neoplastic Cells 12/2019
1	Virus Diseases (Viral Diseases) 07/2013
1	Hematologic Neoplasms (Hematological Malignancy) 07/2013
1	Lentivirus Infections 11/2008
1	Lung Neoplasms (Lung Cancer) 11/2008

Drug/Important Bio-Agent (IBA)

9	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 09/2013
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 11/2008
3	PlasticsIBA 11/2022 - 10/2016
3	AntibodiesIBA 01/2022 - 11/2014
3	human ERBB2 proteinIBA 01/2022 - 10/2015
2	RNA (Ribonucleic Acid)IBA 04/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2019
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 01/2019
2	TubulinIBA 01/2020 - 05/2015
2	AntigensIBA 10/2018 - 03/2011
2	SurvivinIBA 01/2016 - 09/2015
2	Peptides (Polypeptides)IBA 09/2015 - 12/2014
2	AgarIBA 11/2008 - 12/2007
1	CreatineIBA 12/2023
1	methixene (metixene)FDA Link 10/2023
1	CaspasesIBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 04/2023
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2023
1	tucatinibIBA 01/2022
1	signal sequence receptorIBA 01/2022
1	taxaneIBA 01/2022
1	olfactomedinIBA 01/2022
1	pertuzumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	purineIBA 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020
1	Single-Domain AntibodiesIBA 12/2019
1	IntegrinsIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	ChromatinIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Fatty Acid-Binding Protein 7IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	LipidsIBA 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2019
1	ChemokinesIBA 10/2016
1	OsteoprotegerinIBA 10/2016
1	VaccinesIBA 07/2015
1	NestinIBA 05/2015
1	Antiviral Agents (Antivirals)IBA 02/2015
1	GoldIBA 12/2014
1	Trans-Activators (Trans-Acting Factor)IBA 12/2014
1	GD3 ganglioside (GD(3))IBA 12/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014
1	Contrast MediaIBA 12/2014
1	Heme Oxygenase-1IBA 01/2014
1	EnzymesIBA 01/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2014
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 01/2014
1	AntioxidantsIBA 11/2013
1	N-AcetylcysteinamideIBA 11/2013
1	Sulfhydryl Compounds (Thiols)IBA 11/2013
1	LigandsIBA 03/2013
1	CytokinesIBA 01/2013
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2012
1	Chemotactic FactorsIBA 09/2011
1	Small Interfering RNA (siRNA)IBA 11/2008
1	Uridine Triphosphate (UTP)IBA 11/2008
1	ErbB Receptors (EGF Receptor)IBA 11/2008
1	Peptide Hydrolases (Proteases)FDA Link 11/2008
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2008
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2007
1	Monomeric GTP-Binding ProteinsIBA 12/2007

Therapy/Procedure

26	Therapeutics 01/2023 - 10/2010
11	Drug Therapy (Chemotherapy) 01/2023 - 09/2013
5	Radiotherapy 12/2023 - 01/2012
5	Oncolytic Virotherapy 01/2016 - 03/2010
2	Immunotherapy 01/2023 - 11/2022
1	RNAi Therapeutics 01/2017
1	Biological Therapy 01/2016
1	Intravenous Administration 12/2014
1	Injections 11/2008